Last reviewed · How we verify

NCT05772845: VASP

Vaping and Smoking Withdrawal Project

Recruiting now NA Last updated 9 March 2026
What this trial tests

NA trial testing Acute (24-hour) abstinence in Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) in 370 participants. Currently enrolling.

Timeline
14 February 2023
Primary endpoint
30 November 2026
30 November 2026

Quick facts

Lead sponsorState University of New York at Buffalo
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment370
Start date14 February 2023
Primary completion30 November 2026
Estimated completion30 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

State University of New York at Buffalo

Who can join

Adults 21 to 50, any sex, with Acute Abstinence From Cigarettes vs E-cigarettes (ENDS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed research, which will systematically and comprehensively characterize the withdrawal among daily vapers compared to daily smokers of combustible cigarettes, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence/abuse liability and contributing to the development of therapies for tobacco/nicotine use, the leading preventable cause of death in the US.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acute (24-hour) abstinence

Trials testing the same drug.

Other recruiting trials for Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)

Currently open trials in the same condition.

Other State University of New York at Buffalo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing